Page last updated: 2024-11-03

pyridinolcarbamate and Movement Disorders

pyridinolcarbamate has been researched along with Movement Disorders in 1 studies

Pyridinolcarbamate: A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408)

Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zelikovsky, A1
Urca, I1
Shaklai, M1
de Vries, A1

Trials

1 trial available for pyridinolcarbamate and Movement Disorders

ArticleYear
A clinical trial with pyridinolcarbamate in the treatment of patients with obstructive diseases of the peripheral arteries.
    Japanese heart journal, 1973, Volume: 14, Issue:1

    Topics: Aged; Arterial Occlusive Diseases; Arteriosclerosis; Carbamates; Female; Femoral Artery; Gait; Human

1973